Tau and amyloid PET and ultra-high-field MRI study in patients with psychiatric disorders in middle and late life

Tau and amyloid PET and ultra-high-field MRI study in patients with psychiatric disorders in middle and late life - PET and MRI study in patients with psychiatric disorders in middle and late life

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000046196

Enrollment

150

Registered

2022-01-04

Start date

2022-07-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

psychiatric disorders

Interventions

healthy controls patients with psychiatric disorders

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Participants who can understand the content of this study. Each patient must meet the diagnostic criterion.

Exclusion criteria

Exclusion criteria: Subjects with severe neurological diseases Strong claustrophobia Subjects during (probable) pregnancy or breast-feeding

Design outcomes

Primary

Measure	Time frame
Distribution of tau and amyloid in the brain	—

Countries

Japan

Contacts

Public ContactManabu Kubota

Kyoto University Department of Psychiatry

kupsy.research8@gmail.com075-751-3386

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026